Bayer bets on ‘silver bullet’ defense in Roundup litigation; experts see hurdles
NEW YORK (Reuters) – Bayer AG plans to argue that a $2 billion jury award and thousands of U.S. lawsuits…
Bayer bets on ‘silver bullet’ defense in Roundup litigation; experts see hurdles
NEW YORK (Reuters) – Bayer AG plans to argue that a $2 billion jury award and thousands of U.S. lawsuits…
U.S. states accuse Teva, other drugmakers, of price-fixing: lawsuit
WASHINGTON (Reuters) – U.S. states filed a lawsuit accusing Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19…
U.S. states accuse Teva, other drugmakers, of price-fixing: lawsuit
WASHINGTON (Reuters) – U.S. states filed a lawsuit accusing Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19…
The obscure advisory committees at the heart of the U.S. drug pricing debate
CHICAGO (Reuters) – Expectations were high last year for three new migraine drugs hitting the market from Amgen Inc, Eli…
U.S. measles outbreak raises questions about immunity in adults
(Reuters) – Adults in the United States who were vaccinated against measles decades ago may need a new dose depending…
FDA approves expanded label for Regeneron/Sanofi’s cholesterol drug
(Reuters) – The U.S. Food and Drug Administration on Friday approved Regeneron Pharmaceuticals Inc’s cholesterol drug Praluent as a treatment…
Merck’s Keytruda wins FDA approval as combination therapy for kidney cancer
FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey,…
Second death in Novartis gene therapy trials under investigation
(Reuters) – Novartis AG, which this week announced positive interim trial results for its experimental gene therapy for spinal muscular…
Zogenix’s seizure drug filing fails to pass U.S. FDA scrutiny
(Reuters) – The U.S. Food and Drug Administration on Monday refused to fully review the marketing application for Zogenix Inc’s…
New Jersey jury finds J&J not liable in latest talc cancer trial
(Reuters) – A New Jersey jury on Wednesday cleared Johnson & Johnson of liability in a lawsuit brought by a…
J&J settles three mesothelioma talc cases-plaintiffs’ lawyer
A bottle of Johnson and Johnson Baby Powder is seen in a photo illustration taken in New York, February 24,…
New Jersey jury finds J&J not liable in latest talc cancer trial
(Reuters) – A New Jersey jury on Wednesday cleared Johnson & Johnson of liability in a lawsuit brought by a…
FDA rejects Sanofi-Lexicon add-on pill for type 1 diabetes
(Reuters) – The U.S. Food and Drug Administration declined to approve a drug developed by Sanofi SA and Lexicon Pharmaceuticals…
Jazz Pharma’s sleep disorder treatment gets FDA nod
(Reuters) – The U.S. Food and Drug Administration approved Jazz Pharmaceuticals Plc’s treatment for patients with a form of sleep…
FDA approves generic valsartan amid drug shortage
(Reuters) – The U.S. Food and Drug Administration said on Tuesday it had approved a new generic version of blood…
FDA approves Pfizer’s biosimilar to Roche’s Herceptin
FILE PHOTO: The logo of U.S. pharmaceutical corporation Pfizer Inc. is seen at a branch in Zurich, Switzerland October 2,…
J&J nasal spray gets U.S. approval as first new type of anti-depressant in decades
(Reuters) – The U.S. Food and Drug Administration on Tuesday said it approved a Johnson & Johnson nasal spray antidepressant…
FDA chief tough on e-cigs steps down in surprise resignation
WASHINGTON (Reuters) – U.S. Food and Drug Administration Commissioner Scott Gottlieb said on Tuesday that he plans to step down…
U.S. seeks to cut dialysis costs with more home care versus clinics
(Reuters) – The Trump administration is working on a new payment approach for treating kidney disease that favors lower cost…
New cancer-causing toxin found in recalled blood pressure pills
(Reuters) – U.S. health regulators said on Friday a third cancer-causing toxin was found in some blood pressure pills recalled…
U.S. Senator Sanders urges FDA to allow older versions of $375,000 drug
(Reuters) – U.S. Senator Bernie Sanders this week urged regulators to allow pharmacies and manufacturers to resume distributing unbranded, lower-cost…
J&J becomes first drugmaker to add prices to television ads
FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike Blake/File Photo CHICAGO…
Sanofi blood disorder drug wins FDA approval
(Reuters) – The U.S. Food and Drug Administration (FDA) said on Wednesday it had approved Sanofi SA’s drug to treat…
FDA approves cheaper Botox rival to treat frown lines
(Reuters) – An injection that makes forehead wrinkles disappear is set to rival Allergan’s Botox after U.S. regulators approved Evolus…
Salmonella outbreak linked to raw turkey leaves over 200 sick across U.S.
(Reuters) – More than 200 people from across the United States have fallen ill, 84 of them hospitalized, from an…
FDA panel backs prescribing opioid overdose reversal drug along with painkillers
(Reuters) – An advisory panel to the U.S. Food and Drug Administration on Tuesday recommended prescribing the opioid overdose reversal…
BrainStorm gets FDA okay for stem cell trial in MS patients
TEL AVIV (Reuters) – BrainStorm Cell Therapeutics Inc has received approval from the U.S. Food and Drug Administration to begin…
Evofem shares surge as contraceptive gel meets late-stage trial goal
(Reuters) – Shares of Evofem Biosciences Inc jumped as much as 38 percent on Monday after its birth control gel…
E-cigarette usage nearly doubles in U.S. high-schools: survey
A young man smokes an electronic cigarette in this picture illustration taken September 14, 2018. REUTERS/Mike Blake/Illustration (Reuters) – The…
Olympus unit pleads guilty to resolve U.S. duodenoscope probe
(Reuters) – An Olympus Corp subsidiary pleaded guilty on Monday and agreed to pay $85 million to resolve charges that…
U.S. regulators snip red tape for medical devices to curb opioid crisis
(Reuters) – Laura Perryman expected her medical company, Stimwave Technologies Inc, would have to wait several years for its painkilling…
Sanofi drug Dupixent wins FDA approval to treat asthma
(Reuters) – France’s Sanofi SA said on Friday eczema drug Dupixent was approved by the U.S. Food and Drug Administration…
Insmed’s treatment-resistant lung disease drug gets FDA approval
(Reuters) – The U.S. Food and Drug Administration on Friday approved Insmed Inc’s lead drug to treat a rare, chronic…
Special Report: Juul copycats flood e-cig market, despite FDA rule
(Reuters) – The sleek Juul electronic cigarettes have become a phenomenon at U.S. high schools, vexing educators and drawing regulatory…
EU approves fifth copy of AbbVie’s $18 billion drug Humira
LONDON (Reuters) – Europe has approved a fifth copy of AbbVie’s $18-billion-a-year biologic drug Humira – the world’s best-selling prescription…
AstraZeneca plots China robot offensive to counter price cuts
WUXI, China/LONDON (Reuters) – With smart cancer diagnostics, one-stop-shop diabetes kits and AI systems to improve ambulance pick-ups for patients…
U.S. regulator approves Teva migraine drug, shares rise
(Reuters) – Shares of Israeli drugmaker Teva Pharmaceutical Industries rose over 5 percent in after-hours trading on Friday after the…
Merck KGaA, Pfizer’s immuno-drug shown to alleviate kidney cancer
FRANKFURT (Reuters) – Merck KGaA said that its immunotherapy Bavencio, jointly developed with Pfizer, delayed the progression of kidney cancer…
Israeli radiation therapy firm Alpha Tau raises $29 million
TEL AVIV (Reuters) – Alpha Tau Medical, an Israeli developer of alpha radiation cancer therapy, said on Wednesday it raised…
UK rejects Gilead’s CAR-T cancer cell therapy as too expensive
LONDON (Reuters) – A cutting-edge CAR-T cell therapy for otherwise untreatable forms of blood cancer is too expensive to justify…
Bayer, J&J’s heart drug Xarelto fails trial to widen use
FRANKFURT (Reuters) – Bayer and Johnson & Johnson’s campaign to widen the market for its heart drug Xarelto hit a…
Biogen’s pricey muscle drug Spinraza too costly for Britain
LONDON (Reuters) – Biogen’s muscle disease treatment Spinraza has been deemed too expensive for use on Britain’s state-run health service,…
More drugmakers build Brexit stockpiles as EU agency faces exodus
PARIS/ZURICH/LONDON (Reuters) – Sanofi (SASY.PA) and Novartis (NOVN.S) said on Wednesday they planned to increase stockpiles of medicines in Britain…
Bayer hits back at new Netflix medical device documentary
NEW YORK (Reuters) – Bayer AG disputed accusations in a new Netflix documentary that claims medical device makers and the…
Mersana’s cancer drug trial put on hold by FDA; shares halted
(Reuters) – Mersana Therapeutics said on Thursday an early stage trial testing its lead cancer drug has been put on…
Fast-growing e-cigarette maker Juul to launch in UK
LONDON (Reuters) – Silicon Valley e-cigarette start-up Juul Labs is bringing its small flash drive-sized vaping device to the United…
CTI Biopharma’s cancer drug fails late-stage trial, shares tumble
(Reuters) – CTI Biopharma Corp said on Monday its treatment for a type of blood cancer did not meet the…
GSK’s two-drug HIV treatment meets main goal in late stage studies
(Reuters) – GlaxoSmithKline’s two-drug treatment for HIV, the virus that causes AIDS, met its main goal in late stage studies,…
Novartis readies anti-sexism message for migraine drug
ZURICH (Reuters) – With women hardest hit by migraine headaches, Swiss drugmaker Novartis is gearing up its marketing message to…
Leading oncology group wary of Trump drug price proposals
CHICAGO (Reuters) – America’s leading group of cancer doctors is wary of new Trump administration proposals for lowering drug costs,…
TherapeuticsMD’s therapy for menopause-related condition gets approval
(Reuters) – Women’s healthcare company TherapeuticsMD Inc won its first-ever U.S. approval on Wednesday with the drug regulator clearing its…
FDA approves BioMarin rare metabolic disorder drug, shares rise
(Reuters) – U.S. regulators on Thursday approved BioMarin Pharmaceutical Inc’s Palynziq for adults with phenylketonuria, a rare metabolic disorder, sending…
FDA issues warning letters to companies selling kratom products
(Reuters) – The U.S. Food and Drug Administration said on Tuesday it issued warning letters to three companies that illegally…
Jazz Pharmaceuticals to settle U.S. probe for $57 million
BOSTON (Reuters) – Jazz Pharmaceuticals Plc said on Tuesday it had agreed to pay $57 million to resolve a U.S.…
FDA says Mylan’s EpiPen is in shortage
(Reuters) – U.S. regulators said on Wednesday that Mylan NV’s (MYL.O) EpiPen products are in shortage, due to manufacturing delays…
U.S. drug agency suspends Louisiana distributor over opioid sales
WASHINGTON (Reuters) – The U.S. Drug Enforcement Administration said on Friday it had suspended a Louisiana pharmaceutical distributor from selling…
FDA clears Pluristem radiation treatment for emergency use
HAIFA, Israel (Reuters) – Pluristem Therapeutics Inc, a developer of placenta-based stem cell products, said the U.S. Food and Drug…
Ninety-eight now sick from romaine lettuce-linked E. coli: CDC
(Reuters) – Fourteen more people fell ill from an E. coli outbreak linked to romaine lettuce, U.S. health officials said…
Fourteen more fall sick from E. coli linked to romaine lettuce: CDC
(Reuters) – Fourteen more sick people from eight U.S. states were added to an investigation of an E. coli outbreak…